CCEL News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

CC

Mkt Cap

$29.4M

Volume

9.89K

Next Earnings

October 21st

Chart Financials Earnings News About Insider Filings

Cord Blood Banking Services Market: USD 49.85 Bn Opportunity to 2031 Led by Stem Cell Advancements, Says Mordor IntelligenceThe global cord blood banking services market is projected to grow from USD 33.85 billion in 2025 to USD 49.85 billion by 2031, with a CAGR of 6.84%. Growth is driven by increasing awareness of stem cell therapies, advancements in regenerative medicine, and expanding clinical applications in treating hematological and genetic disorders. North America leads with 39.54% market share, while Asia-Pacific emerges as a high-growth region.GlobeNewswire Inc. · Feb 27, 2026

Stem Cell Banking Market to Surpass Value of USD 18.65 Billion By 2031 | SkyQuest TechnologyThe global stem cell banking market is projected to reach $18.65 billion by 2031, growing at a CAGR of 18.30% due to advancements in cryopreservation, cell bank preparation, and the rising adoption of stem cell therapy. The market is driven by increased awareness of stem cell therapy, growing healthcare investments, and trends in personalized medicine.GlobeNewswire Inc. · Dec 16, 2024

Stem Cell Banking Market to Surpass Value of USD 18.65 Billion By 2031 | SkyQuest TechnologyThe global stem cell banking market is expected to reach a value of USD 18.65 Billion by 2031, growing at a CAGR of 18.30% during the forecast period. The market is driven by advancements in cryopreservation, increased application of stem cell treatments, and the trend of late parenting leading to interest in cord blood banking.Benzinga · Dec 16, 2024

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2022OLDSMAR, Fla., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2022.GlobeNewswire Inc. · Feb 28, 2023

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial ResultsOLDSMAR, Fla., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2022.GlobeNewswire Inc. · Oct 14, 2022

Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From YesterdayLosers KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) shares dipped 58.9% to close at $5.85 on Tuesday after the company announced it terminated the KOMPLETE phase 2 clinical trial for KVD824 for the prevention of attacks in people with hereditary angioedema. Oblong, Inc (NASDAQ: OBLG) fell 40.3% to close at $0.2390 after jumping 167% on Monday. FaZe Holdings Inc. (NASDAQ: FAZE) fell 39.1% to close at $4.96 after the company issued a filing showing issuance of up to roughly 5.92 million shares of common stock, the resale of up to roughly 64 million shares of common stock and the resale of roughly 173,000 warrants. FedNat Holding Company (NASDAQ: FNHC) shares fell 37% to close at $0.2963 after surging around 309% on Monday. Verastem, Inc. (NASDAQ: VSTM) dropped 34.6% to close at $0.5718 after the company announced RAMP VS-6766 clinical trials and corporate updates. Rallybio Corporation (NASDAQ:Benzinga · Oct 5, 2022

Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day SessionGainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy. Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 44.3% to $4.7893 after Alliance Global Partners initiated coverage on the stock with a Buy rating and a $20 price target. IMARA Inc. (NASDAQ: IMRA) rose 37% to $1.57 after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontrine and other assets of its PDE9 program for $34.75 million upfront. Sidus Space, Inc. (NASDAQ: SIDU) gained 26.7% to $3.3701 after the company announced that it has signed a launch agreement with SpaceX for five launches, beginning in early 2023. Cryo-Cell International, Inc. (NYSE: CCEL) jumped 17.7% to $7.86. bioAffinity Technologies, Inc. (NASDAQ: BIAF) rose 19.7% to $6.45 after dropping around 24% on Tuesday. The company, last week, priced its IPO at $6.125 per unit. Azure Power Global Limited (NYSE: AZRE) shares gained 17.3% to $4.21. Azure Power Global recently announced the resignation of Harsh Shah as CEO. Pingtan Marine Enterprise Ltd. (NASDAQ: PME) jumped 17.3% to $0.8565. Glaukos Corporation (NYSE: GKOS) gained 17.3% to $56.40 after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved its pre-specified primary efficacy endpoints through 3 months in both Phase 3 trials and demonstrated excellent tolerability and a favorable safety profile through 12 months. Aquestive Therapeutics, Inc. (NASDAQ: AQST) rose 16.8% to $1.4599. Oppenheimer initiated coverage on Aquestive Therapeutics with an Outperform rating and announced a price target ...Benzinga · Sep 7, 2022

Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022Upgrades According to Argus Research, the prior rating for AstraZeneca PLC (NASDAQ:AZN) was changed from Hold to Buy. For the second quarter, AstraZeneca had an EPS of $0.86, compared to year-ago quarter EPS of $0.45. At the moment, the stock has a 52-week-high of $71.70 and a 52-week-low of $55.50. AstraZeneca closed at $66.32 at the end of the last trading period. According to RBC Capital, the prior rating for The Toronto-Dominion Bank (NYSE:TD) was changed from Sector Perform to Outperform. In the third quarter, Toronto-Dominion Bank showed an EPS of $1.62, compared to $1.60 from the year-ago quarter. At the moment, the stock has a 52-week-high of $86.02 and a 52-week-low of $58.64. Toronto-Dominion Bank closed at $66.60 at the end of the last trading period. For Apple Hospitality REIT Inc (NYSE:APLE), Wells Fargo upgraded the previous rating of Underweight to Equal-Weight. In the second quarter, Apple Hospitality REIT showed an EPS of $0.48, compared to $0.30 from the year-ago quarter. The stock has a 52-week-high of $18.69 and a 52-week-low of $14.29. At the end of the last trading period, Apple Hospitality REIT closed at $16.34. For Park Hotels & Resorts Inc (NYSE:PK), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. For the second quarter, Park Hotels & Resorts had an EPS of $0.61, compared to year-ago quarter EPS of $0.16. The stock has a 52-week-high of $20.57 and a 52-week-low of $12.90. At the end of the last trading period, Park Hotels & Resorts closed at $14.22. For Host Hotels & Resorts Inc (NASDAQ:HST), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. In the second quarter, Host Hotels & Resorts showed an EPS of $0.58, compared to $0.12 from the year-ago quarter. The current stock performance of Host Hotels & Resorts shows a 52-week-high of $21.63 and a 52-week-low of $15.10. Moreover, at the end of the last trading period, the closing price was at $18.24. For Calithera Biosciences Inc (NASDAQ:CALA), HC Wainwright & Co. upgraded the previous rating of Neutral to Buy. In the second quarter, Calithera Biosciences showed an EPS of $1.59, compared to $3.80 from the year-ago quarter. The current stock performance of Calithera Biosciences shows a 52-week-high of $5.10 and a 52-week-low of $0.14. Moreover, at the end of the last trading period, the closing price was at $3.27. According to Piper Sandler, the prior rating for Envista Holdings Corp (NYSE:NVST) was changed from Neutral to Overweight. Envista Holdings earned $0.48 in the second quarter, compared to $0.53 in the year-ago quarter. At the moment, the stock has a 52-week-high of $52.03 and a 52-week-low of $35.24. Envista Holdings closed at $36.60 at the end of the last trading period. See all analyst ratings upgrades. Downgrades For Jowell Global Ltd (NASDAQ:JWEL), TD Securities downgraded the previous rating of Buy to Action List Buy. NoneThe stock has a 52-week-high of $25.78 and a 52-week-low of $0.96. At the end of the last trading period, Jowell Global closed at $1.23. Consumer Edge Research downgraded the previous rating for The Hain Celestial Group Inc (NASDAQ:HAIN) from Overweight to Equal-Weight. For the fourth quarter, Hain Celestial Group had an EPS of $0.08, compared to year-ago quarter EPS of $0.39. The stock has a 52-week-high of $43.53 and a 52-week-low of $21.20. At the end of the last trading period, Hain Celestial Group closed at $21.28. According to JMP Securities, the prior rating for Avalara Inc (NYSE:AVLR) was changed from Market Outperform to Market Perform. Avalara earned $0.02 in the second quarter, compared to $0.02 in the year-ago quarter. The stock has a 52-week-high of $129.34 and a 52-week-low of $66.39. At the end of the last trading period, Avalara closed ...Full story available on Benzinga.comBenzinga · Aug 29, 2022

Cord Blood Banking Leader Cryo-Cell Announces Special Cash DividendOLDSMAR, Fla., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (“Cryo-Cell”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced today that its Board of Directors declares a one-time, special cash dividend of $0.90 per share of common stock to be paid to its shareholders of record as of the close of business on September 2, 2022.GlobeNewswire Inc. · Aug 22, 2022

Cord Blood Banking Leader Cryo-Cell Announces Transfer to the NYSE American Stock ExchangeOLDSMAR, Fla., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (“Cryo-Cell”, the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced today that it will change its listing from the Nasdaq Capital Market to the NYSE American stock exchange on August 30, 2022.GlobeNewswire Inc. · Aug 17, 2022

CC

CCELCryo-Cell International Inc.

CCEL

Pay with—

Available Balance0.00

Your PositionYou don't own any CCEL yet.

Related Tickers

Earnings